Cholesterol-lowering statins such as Lipitor (atorvastatin) and Crestor (rosuvastatin calcium) are among the most widely ...

AstraZeneca is to sell European rights to its cholesterol drug Crestor (rosuvastatin) to Germany’s Grunenthal. Crestor is a statin and at its peak generated annual revenues of more than $7 ...

The authors assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic ...

Dosing a statin (rosuvastatin) every other day (EOD) may provide significant lipoprotein changes while avoiding common adverse effects in this statin-intolerant population. Objective: To determine ...

rosuvastatin (Crestor), to some groups of people who don’t even have high cholesterol. The move was prompted by a 2008 study called JUPITER, which showed that taking rosuvastatin reduced participants’ ...

Crestor was first tested on 12,000 patients ... On the potential downside of rosuvastatin, Dr Roberts pointed out that there were no long-term outcome studies with such a new statin.

Two high-value medications were chosen for the pilot program: Lantus® Pens and Rosuvastatin, the generic version of Crestor®. Participation is automatic. The pilot program will run for up to ...